Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635) has released its third independent annual Sustainability Report for the financial year 2023-24, under the theme 'Building Resilience Today for a Sustainable Tomorrow.' The report highlights Piramal Pharma's approach across four key strategic pillars: Responsible Operations, Business Resilience, Customer Centricity, and Quality & Excellence. These pillars underscore the company's focus on climate action, supply chain responsibility, innovation, and operational excellence, all while ensuring the well-being of its employees and the communities it serves.
Read more...
About the Author
EcoVadis is a purpose-driven company dedicated to embedding sustainability intelligence into every business decision worldwide. We offer a full range of solutions including IQ-Plus Risk & Compliance Management, EcoVadis Ratings, and Carbon Action Module for Scope 3 Decarbonization. Key features like 360/Live News Monitoring, Academy E-learning and Corrective action plans help companies comply with ESG regulations, reduce GHG emissions, and improve the sustainability performance of their business and value chain across 250 industries in 185 countries.
Follow on Linkedin
Visit Website
More Content by EcoVadis EN